Philips Sees China Health Care Slump Weighing on Growth

Lock
This article is for subscribers only.

Royal Philips NV expects lower demand in China to continue to stymie growth for the Dutch medical equipment maker this year.

While Philips expects comparable sales to expand as much as 3% in 2025, the headwinds in the Asian nation prevent a better result, it said Wednesday. The company forecasts a mid- to high-single-digit sales decline in China this year. Its shares fell the most since October.